2 P.A.C.E. contact hour(s)

(based on 794 customer ratings)

Course provided by LabCE.

See more courses in: Immunology / Serology

Continuing Education Credits

P.A.C.E.® Contact Hours (acceptable for AMT, ASCP, and state recertification): 2 hour(s)
Course number 578-023-17, approved through 7/31/2019
Florida Board of Clinical Laboratory Personnel Credit Hours - General (Serology/Immunology): 2 hour(s)
Course number 20-584775, approved through 9/1/2020


  • Understand the virology and pathogenesis of the Zika virus.
  • Describe the modes of transmission, symptoms, and infection risks.
  • Determine the risk of Zika virus infection during pregnancy and the evaluation and consequences of congenital infections.
  • Discuss the diagnosis of Zika virus infection using a combination of clinical symptoms, history, and diagnostic testing.
  • Define the main laboratory tests used for Zika virus identification, including RT-PCR, Zika IgM ELISA and plaque reduction neutralization tests (PRNT).
  • Review the latest Centers for Disease Control and Prevention (CDC) guidelines on Zika virus testing and diagnosis, with emphasis on the evaluation of women and newborns with peripartum Zika virus exposure.
  • Examine the prevention and treatment of Zika virus infections and the status of vaccine development.
  • Review the CDC's Zika virus testing algorithms for symptomatic and asymptomatic individuals.

Customer Ratings

(based on 794 customer ratings)

Course Outline

  • Introduction: Virology and Transmission
      • Virology and Transmission
      • Virology and Transmission (continued)
  • History
      • Transmission History
  • Symptoms, Infection, and Risks
      • Symptoms of Zika Infection
      • Clinical Manifestation and Congenital Zika Virus Infection
      • Zika Virus Infection Risks
  • Patient Management: General population, Pregnancy, and Newborns
      • Zika Management for the General Population
      • Zika Virus Infection Management for Pregnant Women
      • Zika Virus Infection Management for Women Wanting to Become Pregnant
      • Zika Virus Infection Management for Women Wanting to Prevent Pregnancy
      • Newborn Management, Evaluation, and Follow-up
  • Diagnosis and Laboratory Testing
      • Overview: Diagnosis and Testing
      • Overview: Diagnosis and Testing (continued)
      • Specimen Types and Collection
    • Laboratory Tests Used for Zika Virus Identification
      • Zika Virus Testing Information Available for Laboratories
      • CDC-Approved Zika Assays and Qualified Laboratories
      • Information for Laboratories: Diagnostic Tests and Emergency Use Authorization (EUA)
      • Real-Time Reverse Transcription-Polymerase Chain Reaction (rRT-PCR)
      • Trioplex Real-Time RT-PCR Assay
      • Zika IgM ELISA (Zika MAC-ELISA)
      • Zika MAC-ELISA: Key Facts
      • Plaque Reduction Neutralization Tests (PRNT)
      • Key Considerations: Interpreting and Reporting Zika Test Results
    • CDC Guidelines on Zika Virus Testing and Diagnosis
      • Overview and Testing Algorithms: Pregnant or Non-Pregnant Symptomatic Individuals
      • Overview and Testing Algorithm: Asymptomatic Pregnant Women
  • Prevention, Treatment and Vaccine Development
      • Prevention
      • Treatment
      • Vaccine Development
  • Summary and Recommendations
      • Summary and Recommendations:
      • Summary and Recommendations (continued)
      • Links to CDC and FDA Zika Information Updates
  • References
      • References
How to Subscribe
Single online course$20
Add to cart
  • Order for instant access through any computer, any browser.
  • No shipping, faxing, or waiting for certificates.
  • Print or save your certificate of completion as soon as you've completed the course.
  • You'll have 90 days to complete your purchased courses.
Course provided by LabCE.

ASCLS CE's design and platform are provided by MediaLab, Inc.